Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Headaches Clinical Trials

A listing of Headaches medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (231) clinical trials

Acute Migraines – Moderate to Severe

Phase N/A

Are your migraines not under control? Wake Research Associates is enrolling volunteers with migraines in a research study testing an investigational medication.   Other Details:Qualified participants may receive:-Study-related medication at no cost-Study-related medical exams at no cost-Compensation for time and travelInsurance is not needed to participate in this study

Phase N/A

  In this research study, doctors want to test the safety and effectiveness of the study drug for the acute treatment of Migraine.    Length of study: up to 54 weeks   Number of office visits: up to 18 visits   At no cost, qualified participants will receive:   Study-related ...

Phase N/A

Protocol:  IPX229-B16-01 This is a study to evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years.

Phase

Protocol #: 20150308 Migraine prevention in Subjects with Chronic Migraine (CM) or Episodic Migraine (EM) comparing the treatment medication AMG 301 to placebo.

Phase

Rimegepant is being developed for the treatment of migraine, with a specific focus on acute treatment. Effectiveness against migraine was demonstrated in a Phase 2b double-blind, randomized, placebocontrolled, dose-ranging study where rimegepant at 75 mg showed efficacy on all four traditional endpoints: pain, nausea, photophobia and phonophobia.

Phase

To assess the single dose PK of galcanezumab administered via subcutaneous injection in a population of pediatric patients aged 6 to 17 years with migraine

Phase

This is a placebo controlled trial to test the efficacy and safety of AMG 301 in the prevention of episodic and chronic migraine. The treatment period is 12 weeks and the total study duration is 35 weeks.

Phase

This is a 28 week study requiring a total of 3 clinic visits. Subjects will be treated with either a placebo or the study drug which is given intranasally. 

Phase

The primary purpose of this migraine study is to determine if the investigational medication, Rimegepan, is effective in comparison to placebo in the acute treatment of moderate to severe migraine headache. After an initial 3-28 day screening period, qualified study participants will enter an up to 45 day treatment period. ...

Phase